American Association for the Study of Liver Diseases (AASLD) 2022 Liver Meeting

PathAI will share a total of five presentations, four of which were developed in collaboration with pharmaceutical partners, at the 2022 AASLD Liver Meeting. New findings for nonalcoholic steatohepatitis (NASH) highlight how PathAI continues to address the need for a reproducible and accurate clinical research network (CRN) scoring tool to meet the standards of today’s NASH clinical trials, as well as the need for more robust quantitative measures.   



November 4 – 8, 2022

Washington, DC
Contact Us  | Learn More


Oral Presentation

Exploratory Analyses of NASH histology using CRN scores derived from a multi-stain machine learning method

Session Date and Time: Monday, November 7, 2022, 2:00 – 3:00 PM ET
Poster: #76
View Abstract

Poster Presentations

Quantitative multimodal anisotropy Imaging enables machine learning prediction of NASH CRN fibrosis stage without manual annotation

Session Date and Time: Saturday, November 5, 2022, 1:00 PM – 2:00 PM ET
Poster: #2548
View Poster

Comparison of the effects of semaglutide on liver histology in patients with non-alcoholic steatohepatitis cirrhosis between machine learning model assessment and pathologist evaluation

Session Date and Time: Saturday, November 5, 2022, 1:00 PM – 2:00 PM ET
Poster: #2681
View Poster

Association between improvement in machine learning-assessed steatosis area and magnetic resonance imaging-proton density fat fraction in patients with compensated non-alcoholic steatohepatitis cirrhosis

Session Date and Time: Saturday, November 5, 2022, 1:00 PM – 2:00 PM ET
Poster: #2682
View Poster

Variability in liver biopsy assessment: Data from the pegozafermin Phase 1b/2a study in subjects with non-alcoholic steatohepatitis (NASH)

Session Date and Time: Saturday, November 5, 2022, 1:00 PM – 2:00 PM ET
Poster: #2683
View Poster